Skip to content

Clinical trials

Terminated Lymphoma, Mantle-Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Status: Terminated Country / region: United States Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20032
20045
20059
20067
20077
200811
20096
201013
20112
20124
201310
20145
20159
20166
20177
20187
20194
20203
20214
20224
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated146

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)14
Fred Hutchinson Cancer Center8
M.D. Anderson Cancer Center8
Masonic Cancer Center, University of Minnesota8
OHSU Knight Cancer Institute6
City of Hope Medical Center5
Case Comprehensive Cancer Center4
Vanderbilt-Ingram Cancer Center4
Barbara Ann Karmanos Cancer Institute3
Gilead Sciences3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell146
Lymphoma, Large B-Cell, Diffuse107
Lymphoma, Follicular104
Leukemia, Lymphocytic, Chronic, B-Cell101
Lymphoma, Non-Hodgkin90
Lymphoma, B-Cell, Marginal Zone85
Precursor Cell Lymphoblastic Leukemia-Lymphoma72
Burkitt Lymphoma71
Hodgkin Disease59
Lymphoma, Large-Cell, Immunoblastic58

Trials

Showing 1 to 25 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.